JPS61161219A - アトピ−性皮膚炎症用化粧料組成物 - Google Patents
アトピ−性皮膚炎症用化粧料組成物Info
- Publication number
- JPS61161219A JPS61161219A JP60001222A JP122285A JPS61161219A JP S61161219 A JPS61161219 A JP S61161219A JP 60001222 A JP60001222 A JP 60001222A JP 122285 A JP122285 A JP 122285A JP S61161219 A JPS61161219 A JP S61161219A
- Authority
- JP
- Japan
- Prior art keywords
- scutellaria
- powder
- composition
- atopic dermatitis
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 206010012438 Dermatitis atopic Diseases 0.000 title abstract description 4
- 201000008937 atopic dermatitis Diseases 0.000 title abstract description 4
- 239000000843 powder Substances 0.000 claims abstract description 15
- 239000002537 cosmetic Substances 0.000 claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 13
- 241000894007 species Species 0.000 claims abstract description 11
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 4
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 4
- 201000004624 Dermatitis Diseases 0.000 claims description 15
- 206010003645 Atopy Diseases 0.000 claims description 12
- 241000207929 Scutellaria Species 0.000 claims description 10
- 239000004615 ingredient Substances 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 9
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 7
- 239000002674 ointment Substances 0.000 abstract description 7
- KGIJOOYOSFUGPC-MSFIICATSA-N 5-Hydroxyeicosatetraenoic acid Chemical compound CCCCCC=CCC=CCC=C\C=C\[C@@H](O)CCCC(O)=O KGIJOOYOSFUGPC-MSFIICATSA-N 0.000 abstract description 6
- KGIJOOYOSFUGPC-CABOLEKPSA-N 5-HETE Natural products CCCCC\C=C/C\C=C/C\C=C/C=C/[C@H](O)CCCC(O)=O KGIJOOYOSFUGPC-CABOLEKPSA-N 0.000 abstract description 5
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 abstract description 3
- 229940015301 baicalein Drugs 0.000 abstract description 3
- 239000006071 cream Substances 0.000 abstract description 3
- 239000006210 lotion Substances 0.000 abstract description 3
- 102000003820 Lipoxygenases Human genes 0.000 abstract description 2
- 108090000128 Lipoxygenases Proteins 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 239000000344 soap Substances 0.000 abstract description 2
- 241000207923 Lamiaceae Species 0.000 abstract 1
- 241000674965 Scutellaria viscidula Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical class CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 208000030961 allergic reaction Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000003246 corticosteroid Substances 0.000 description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 2
- 229960003321 baicalin Drugs 0.000 description 2
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000000750 endocrine system Anatomy 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- KGIJOOYOSFUGPC-XRXZHELTSA-N 5-hydroxyeicosatetraenoic acid Natural products CCCCCC=CCC=CCC=C\C=C\C(O)CCCC(O)=O KGIJOOYOSFUGPC-XRXZHELTSA-N 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000292411 Excoecaria agallocha Species 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102100035792 Kininogen-1 Human genes 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 241000717669 Scutellaria rehderiana Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000009798 acute exacerbation Effects 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001823 pruritic effect Effects 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000009121 systemic therapy Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60001222A JPS61161219A (ja) | 1985-01-08 | 1985-01-08 | アトピ−性皮膚炎症用化粧料組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60001222A JPS61161219A (ja) | 1985-01-08 | 1985-01-08 | アトピ−性皮膚炎症用化粧料組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61161219A true JPS61161219A (ja) | 1986-07-21 |
| JPH0548209B2 JPH0548209B2 (enrdf_load_stackoverflow) | 1993-07-20 |
Family
ID=11495438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60001222A Granted JPS61161219A (ja) | 1985-01-08 | 1985-01-08 | アトピ−性皮膚炎症用化粧料組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61161219A (enrdf_load_stackoverflow) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07118151A (ja) * | 1993-10-21 | 1995-05-09 | Kureha Chem Ind Co Ltd | アトピー性皮膚炎治療剤 |
| JPH0987189A (ja) * | 1995-09-19 | 1997-03-31 | Ichimaru Pharcos Co Ltd | エンメイソウ、ボタンピ、シソ、アルニカ含有抗アレルギー剤 |
| JP2004532212A (ja) * | 2001-04-05 | 2004-10-21 | ニュー・チャプター・インコーポレーテッド | 改良された抗炎症性ハーブ組成物及び使用方法 |
| JP2005519100A (ja) * | 2002-03-01 | 2005-06-30 | ユニゲン・ファーマシューティカルス・インコーポレーテッド | 効力あるｃｏｘ−２阻害薬としてのフリー−ｂ−環フラボノイドの同定 |
| WO2006123887A1 (en) * | 2005-05-17 | 2006-11-23 | Jeong-Jin Kim | Composition containing herb medicine for treating atopic dermatitis |
| KR100761248B1 (ko) * | 2006-10-12 | 2007-10-04 | 주식회사 유니젠 | 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물 |
| US7972632B2 (en) | 2003-02-28 | 2011-07-05 | Unigen Pharmaceuticals, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
| JP2013147438A (ja) * | 2012-01-17 | 2013-08-01 | Kose Corp | ｃＡＭＰ産生抑制剤 |
| CN104587214A (zh) * | 2015-01-19 | 2015-05-06 | 滨州医学院附属医院 | 一种预防肺癌放疗引起的放射性皮炎的中药 |
| CN104784633A (zh) * | 2015-03-26 | 2015-07-22 | 辽宁中医药大学附属医院 | 一种治疗臀上皮神经炎的外用中药制剂 |
| US9168242B2 (en) | 2002-03-22 | 2015-10-27 | Unigen, Inc. | Isolation of a dual COX-2 and 5-lipdxygenase inhibitor from Acacia |
| US9370544B2 (en) | 2002-04-30 | 2016-06-21 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| US9622964B2 (en) | 2003-04-04 | 2017-04-18 | Unigen, Inc. | Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5973509A (ja) * | 1982-10-18 | 1984-04-25 | Osaka Chem Lab | オウゴン含有化粧料組成物 |
| JPS6150918A (ja) * | 1984-08-20 | 1986-03-13 | Ichimaru Fuarukosu Kk | バイカリン又はバイカレイン含有化粧料用組成液 |
-
1985
- 1985-01-08 JP JP60001222A patent/JPS61161219A/ja active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5973509A (ja) * | 1982-10-18 | 1984-04-25 | Osaka Chem Lab | オウゴン含有化粧料組成物 |
| JPS6150918A (ja) * | 1984-08-20 | 1986-03-13 | Ichimaru Fuarukosu Kk | バイカリン又はバイカレイン含有化粧料用組成液 |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07118151A (ja) * | 1993-10-21 | 1995-05-09 | Kureha Chem Ind Co Ltd | アトピー性皮膚炎治療剤 |
| JPH0987189A (ja) * | 1995-09-19 | 1997-03-31 | Ichimaru Pharcos Co Ltd | エンメイソウ、ボタンピ、シソ、アルニカ含有抗アレルギー剤 |
| JP2004532212A (ja) * | 2001-04-05 | 2004-10-21 | ニュー・チャプター・インコーポレーテッド | 改良された抗炎症性ハーブ組成物及び使用方法 |
| JP2005519100A (ja) * | 2002-03-01 | 2005-06-30 | ユニゲン・ファーマシューティカルス・インコーポレーテッド | 効力あるｃｏｘ−２阻害薬としてのフリー−ｂ−環フラボノイドの同定 |
| US8535735B2 (en) | 2002-03-01 | 2013-09-17 | Unigen, Inc. | Identification of free-B-ring flavonoids as potent COX-2 inhibitors |
| US9061039B2 (en) | 2002-03-01 | 2015-06-23 | Unigen, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
| US9168242B2 (en) | 2002-03-22 | 2015-10-27 | Unigen, Inc. | Isolation of a dual COX-2 and 5-lipdxygenase inhibitor from Acacia |
| US9849152B2 (en) | 2002-04-30 | 2017-12-26 | Unigen, Inc. | Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent |
| US9655940B2 (en) | 2002-04-30 | 2017-05-23 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| US9370544B2 (en) | 2002-04-30 | 2016-06-21 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| US7972632B2 (en) | 2003-02-28 | 2011-07-05 | Unigen Pharmaceuticals, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
| US9622964B2 (en) | 2003-04-04 | 2017-04-18 | Unigen, Inc. | Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care |
| WO2006123887A1 (en) * | 2005-05-17 | 2006-11-23 | Jeong-Jin Kim | Composition containing herb medicine for treating atopic dermatitis |
| US9623068B2 (en) | 2006-10-12 | 2017-04-18 | Unigen, Inc. | Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria |
| US8771761B2 (en) | 2006-10-12 | 2014-07-08 | Unigen, Inc. | Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria |
| KR100761248B1 (ko) * | 2006-10-12 | 2007-10-04 | 주식회사 유니젠 | 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물 |
| JP2013147438A (ja) * | 2012-01-17 | 2013-08-01 | Kose Corp | ｃＡＭＰ産生抑制剤 |
| CN104587214A (zh) * | 2015-01-19 | 2015-05-06 | 滨州医学院附属医院 | 一种预防肺癌放疗引起的放射性皮炎的中药 |
| CN104784633A (zh) * | 2015-03-26 | 2015-07-22 | 辽宁中医药大学附属医院 | 一种治疗臀上皮神经炎的外用中药制剂 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0548209B2 (enrdf_load_stackoverflow) | 1993-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS61161219A (ja) | アトピ−性皮膚炎症用化粧料組成物 | |
| ES2206511T3 (es) | Extracto de pantas chinas. | |
| Wu et al. | Anti-inflammatory/Anti-oxidative stress activities and differential regulation of Nrf2-mediated genes by non-polar fractions of tea Chrysanthemum zawadskii and licorice Glycyrrhiza uralensis | |
| Sankeshwari et al. | Soxhlet versus cold maceration: Which method gives better antimicrobial activity to licorice extract against: Streptococcus mutans:? | |
| Homma et al. | Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics | |
| CN103533947A (zh) | 用于治疗和预防感染的植物提取物 | |
| US10695391B2 (en) | Extract from Indigo Naturalis and a process for preparing the same | |
| CN102743402B (zh) | 人参二醇皂苷组分在制备防治皮炎和疤痕药物中的用途 | |
| US10987389B2 (en) | Anti-tumor traditional Chinese medicine microbial fermentation preparation and a preparation method and application thereof | |
| WO2000054793A1 (en) | Pharmaceutical composition comprising mixed aqueous extract of anemarrhena rhizoma and phellodendron bark for analgesic and anti-inflammation | |
| Li et al. | Oligosaccharides isolated from Rehmannia glutinosa protect LPS-induced intestinal inflammation and barrier injury in mice | |
| Chirisa et al. | Evaluation of in vitro anti-inflammatory and antioxidant activity of selected Zimbabwean plant extracts | |
| JPH0516413B2 (enrdf_load_stackoverflow) | ||
| Galle et al. | Analytical and pharmacological studies on Mahonia aquifolium | |
| JPS5838209A (ja) | タンニン配合皮膚外用剤組成物 | |
| CN105342933B (zh) | 一种中药复方洁面泡腾片及其制备方法 | |
| Singh et al. | An investigation of traditional uses and anti-inflammatory property of Clematis buchananiana De Candolle and Tupistra nutans Wall. ex Lindl.: Native ethnomedicinal plants from Sikkim, India | |
| EP2845624B1 (en) | Mucoadhesive devil's claw extracts (harpagophytum procumbens) and uses thereof | |
| JP2000001432A (ja) | アンドロゲン受容体結合阻害剤 | |
| CN104288158B (zh) | 一种含丹参酮的皮肤清洗液的制备方法 | |
| CN111096938B (zh) | 一种含一点红中药提取物及其在制备护肤品中的应用 | |
| JPS61291524A (ja) | ガジュツを原料とする抗アレルギー食品 | |
| JPS609455A (ja) | 特定たで科植物から抽出されたスチルベン化合物を主要成分とする食品 | |
| Cho et al. | Effect of DHU001, a polyherbal formula on formalin-induced paw chronic inflammation of mice | |
| Petchsomrit et al. | High-performance liquid chromatography quantitative determination of oxyresveratrol and morin contained in Maclura cochinchinensis extract and gel formulation |